Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Total 13F shares
-
113,095,261
-
Share change
-
+2,285,427
-
Total reported value
-
$3,384,210,971
-
Put/Call ratio
-
92%
-
Price per share
-
$29.93
-
Number of holders
-
133
-
Value change
-
+$67,735,824
-
Number of buys
-
63
-
Number of sells
-
50
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q1 2022
As of 31 Mar 2022,
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,095,261 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, DRIEHAUS CAPITAL MANAGEMENT LLC, Bellevue Group AG, Casdin Capital, LLC, and JPMORGAN CHASE & CO.
This page lists
133
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.